Provided by Tiger Trade Technology Pte. Ltd.

Amneal Pharmaceuticals, Inc.

20.30
+0.23001.15%
Post-market: 20.440.1400+0.69%19:53 EDT
Volume:2.81M
Turnover:56.91M
Market Cap:6.48B
PE:42.22
High:20.54
Open:20.19
Low:20.00
Close:20.07
52wk High:21.18
52wk Low:9.56
Shares:319.00M
Float Shares:191.00M
Volume Ratio:0.84
T/O Rate:1.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4808
EPS(LYR):0.2200
ROE:613.02%
ROA:8.60%
PB:196.09
PE(LYR):92.27

Loading ...

U.S. Research Roundup-Argan, Mastec, Oracle

Reuters
·
Sep 09

Amneal Pharma: Selling Stockholders May Offer & Sell from Time to Time up to 28,942,098 Shares of Class a Common Stock- SEC Filing

THOMSON REUTERS
·
Sep 04

Amneal Pharmaceuticals Price Target Announced at $22.00/Share by JP Morgan

Dow Jones
·
Aug 26

U.S. Research Roundup- Intuit, MongoDB, Zscaler

Reuters
·
Aug 26

Amneal Pharma : JP Morgan Resumes Coverage with Overweight Rating; Target Price $22

THOMSON REUTERS
·
Aug 26

Amneal EVP, Chief Legal Officer Jason B. Daly Sells USD 3.77 Million in Common Shares

Reuters
·
Aug 14

Amneal Completes Acquisition of Kashiv BioSciences

Reuters
·
Aug 10

Amneal Completes Acquisition of Kashiv Biosciences, Creating a Global Biosimilar Leader

THOMSON REUTERS
·
Aug 10

Amneal Pharmaceuticals' (NASDAQ:AMRX) Strong Earnings Are Of Good Quality

Simply Wall St.
·
Aug 07

Amneal Pharmaceuticals - Converts Term Loans to $2.04 Bln; Incurs New $45.20 Mln Term Loan - SEC Filing

THOMSON REUTERS
·
Aug 04

Amneal Reprices Term Loan, Cuts Interest Margin 50 Bps on USD 2.08 Billion Facility

Reuters
·
Aug 04

Amneal Pharmaceuticals is Maintained at Buy by UBS

Dow Jones
·
Aug 04

Amneal Pharmaceuticals Has Favorable Setup for Growth With Product Approvals, Launches, UBS Says

MT Newswires Live
·
Aug 04

UBS Adjusts Price Target on Amneal Pharmaceuticals to $25 From $23, Maintains Buy Rating

MT Newswires Live
·
Aug 03

Did Strong Q2 Results and Higher 2026 Revenue Guidance Just Shift Amneal Pharmaceuticals' (AMRX) Investment Narrative?

Simply Wall St.
·
Aug 03

Amneal Pharmaceuticals Held Special Shareholder Meeting on Kashiv BioSciences Deal

Reuters
·
Aug 01

Amneal Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

U.S. Stocks on the MOVE-Mastercard, Starbucks, Meta

Reuters
·
Jul 30

Stock Track | Amneal Pharmaceuticals Plummets 6.39% as Tepid Guidance Overshadows Q2 Beat

Stock Track
·
Jul 30

Amneal Gains After Slightly Lifting Full-year Forecast, Q2 Beat

Reuters
·
Jul 30